"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_fax","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count"
"GSM157225","Ovarian tumor AM025","GSM157225","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: benign","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","NONE","7129"
"GSM157226","Ovarian tumor AM027","GSM157226","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: borderline","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","NONE","7129"
"GSM157227","Ovarian tumor AM029","GSM157227","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: borderline","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","NONE","7129"
"GSM157228","Ovarian tumor AM030","GSM157228","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: borderline","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","NONE","7129"
"GSM157229","Ovarian tumor AM053","GSM157229","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157229/GSM157229.CEL.gz","7129"
"GSM157230","Ovarian tumor AM076","GSM157230","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","NONE","7129"
"GSM157231","Ovarian tumor AM122","GSM157231","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3, potentially from extra-ovarian origin","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157231/GSM157231.CEL.gz","7129"
"GSM157232","Ovarian tumor AM124","GSM157232","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157232/GSM157232.CEL.gz","7129"
"GSM157233","Ovarian tumor AM125","GSM157233","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157233/GSM157233.CEL.gz","7129"
"GSM157234","Ovarian tumor AM127","GSM157234","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3, post-chemotherapy sample","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157234/GSM157234.CEL.gz","7129"
"GSM157235","Ovarian tumor AM131","GSM157235","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: undetermined, Tumor stage: invasive, small foci of grade 3 tumor","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","NONE","7129"
"GSM157236","Ovarian tumor AM132","GSM157236","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: undetermined, Tumor stage: invasive, small foci of grade 3 tumor","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","NONE","7129"
"GSM157237","Ovarian tumor AM133","GSM157237","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: undetermined, Tumor stage: invasive, small foci of grade 3 tumor","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","NONE","7129"
"GSM157238","Ovarian tumor AM137","GSM157238","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: borderline","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157238/GSM157238.CEL.gz","7129"
"GSM157239","Ovarian tumor AM138","GSM157239","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: borderline","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157239/GSM157239.CEL.gz","7129"
"GSM157240","Ovarian tumor AM144","GSM157240","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: endometrioid, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157240/GSM157240.CEL.gz","7129"
"GSM157241","Ovarian tumor AM178","GSM157241","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157241/GSM157241.CEL.gz","7129"
"GSM157242","Ovarian tumor AM179","GSM157242","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: borderline","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157242/GSM157242.CEL.gz","7129"
"GSM157243","Ovarian tumor AM182","GSM157243","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: endometrioid, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157243/GSM157243.CEL.gz","7129"
"GSM157244","Ovarian tumor AM195","GSM157244","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157244/GSM157244.CEL.gz","7129"
"GSM157245","Ovarian tumor AM196","GSM157245","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: borderline","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157245/GSM157245.CEL.gz","7129"
"GSM157246","Ovarian tumor AM198","GSM157246","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157246/GSM157246.CEL.gz","7129"
"GSM157247","Ovarian tumor AM200","GSM157247","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: endometrioid, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157247/GSM157247.CEL.gz","7129"
"GSM157248","Ovarian tumor AM201","GSM157248","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157248/GSM157248.CEL.gz","7129"
"GSM157249","Ovarian tumor AM202","GSM157249","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157249/GSM157249.CEL.gz","7129"
"GSM157250","Ovarian tumor AM203","GSM157250","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: endometrioid, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157250/GSM157250.CEL.gz","7129"
"GSM157251","Ovarian tumor AM204","GSM157251","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157251/GSM157251.CEL.gz","7129"
"GSM157252","Ovarian tumor AM207","GSM157252","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157252/GSM157252.CEL.gz","7129"
"GSM157253","Ovarian tumor AM208","GSM157253","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157253/GSM157253.CEL.gz","7129"
"GSM157254","Ovarian tumor AM209","GSM157254","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157254/GSM157254.CEL.gz","7129"
"GSM157255","Ovarian tumor AM225","GSM157255","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: benign","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157255/GSM157255.CEL.gz","7129"
"GSM157256","Ovarian tumor AM226","GSM157256","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: benign","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157256/GSM157256.CEL.gz","7129"
"GSM157257","Ovarian tumor AM228","GSM157257","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: benign","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157257/GSM157257.CEL.gz","7129"
"GSM157258","Ovarian tumor AM233","GSM157258","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: benign","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157258/GSM157258.CEL.gz","7129"
"GSM157259","Ovarian tumor AM250","GSM157259","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: mixed, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157259/GSM157259.CEL.gz","7129"
"GSM157260","Ovarian tumor AM252","GSM157260","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: endometrioid, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157260/GSM157260.CEL.gz","7129"
"GSM157261","Ovarian tumor AM253","GSM157261","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: borderline","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157261/GSM157261.CEL.gz","7129"
"GSM157262","Ovarian tumor AM255","GSM157262","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157262/GSM157262.CEL.gz","7129"
"GSM157263","Ovarian tumor AM256","GSM157263","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157263/GSM157263.CEL.gz","7129"
"GSM157264","Ovarian tumor AM259","GSM157264","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: microinvasion of grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157264/GSM157264.CEL.gz","7129"
"GSM157265","Ovarian tumor AM261","GSM157265","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157265/GSM157265.CEL.gz","7129"
"GSM157266","Ovarian tumor AM263","GSM157266","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157266/GSM157266.CEL.gz","7129"
"GSM157267","Ovarian tumor AM268","GSM157267","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157267/GSM157267.CEL.gz","7129"
"GSM157268","Ovarian tumor AM269","GSM157268","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157268/GSM157268.CEL.gz","7129"
"GSM157269","Ovarian tumor AM287","GSM157269","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: undetermined, Tumor stage: invasive, small foci of grade 3 tumor","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157269/GSM157269.CEL.gz","7129"
"GSM157270","Ovarian tumor AM288","GSM157270","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: undetermined, Tumor stage: invasive, small foci of grade 3 tumor","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157270/GSM157270.CEL.gz","7129"
"GSM157271","Ovarian tumor AM289","GSM157271","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157271/GSM157271.CEL.gz","7129"
"GSM157272","Ovarian tumor AM290","GSM157272","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157272/GSM157272.CEL.gz","7129"
"GSM157273","Ovarian tumor AM292","GSM157273","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: undetermined, Tumor stage: invasive, small foci of grade 3 tumor","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157273/GSM157273.CEL.gz","7129"
"GSM157274","Ovarian tumor AM293","GSM157274","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157274/GSM157274.CEL.gz","7129"
"GSM157275","Ovarian tumor AM294","GSM157275","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157275/GSM157275.CEL.gz","7129"
"GSM157276","Ovarian tumor AM311","GSM157276","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: endometrioid, Tumor stage: invasive grade 1","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157276/GSM157276.CEL.gz","7129"
"GSM157277","Ovarian tumor AM313","GSM157277","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 2/3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157277/GSM157277.CEL.gz","7129"
"GSM157278","Ovarian tumor AM315","GSM157278","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 2/3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157278/GSM157278.CEL.gz","7129"
"GSM157279","Ovarian tumor AM317","GSM157279","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157279/GSM157279.CEL.gz","7129"
"GSM157280","Ovarian tumor AM333","GSM157280","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157280/GSM157280.CEL.gz","7129"
"GSM157281","Ovarian tumor AM335","GSM157281","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157281/GSM157281.CEL.gz","7129"
"GSM157282","Ovarian tumor AM339","GSM157282","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157282/GSM157282.CEL.gz","7129"
"GSM157283","Ovarian tumor AM341","GSM157283","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: mixed, Tumor stage: invasive grade 2/3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157283/GSM157283.CEL.gz","7129"
"GSM157284","Ovarian tumor AM344","GSM157284","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: benign","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157284/GSM157284.CEL.gz","7129"
"GSM157285","Ovarian tumor AM345","GSM157285","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157285/GSM157285.CEL.gz","7129"
"GSM157286","Ovarian tumor AM347","GSM157286","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 2, post-chemotherapy sample","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157286/GSM157286.CEL.gz","7129"
"GSM157287","Ovarian tumor AM348","GSM157287","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157287/GSM157287.CEL.gz","7129"
"GSM157288","Ovarian tumor AM349","GSM157288","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157288/GSM157288.CEL.gz","7129"
"GSM157289","Ovarian tumor AM354","GSM157289","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157289/GSM157289.CEL.gz","7129"
"GSM157290","Ovarian tumor AM364","GSM157290","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: mucinous, Tumor stage: borderline","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","low malignant potential","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157290/GSM157290.CEL.gz","7129"
"GSM157291","Ovarian tumor AM367","GSM157291","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157291/GSM157291.CEL.gz","7129"
"GSM157292","Ovarian tumor AM368","GSM157292","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157292/GSM157292.CEL.gz","7129"
"GSM157293","Ovarian tumor AM381","GSM157293","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157293/GSM157293.CEL.gz","7129"
"GSM157294","Ovarian tumor AM382","GSM157294","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157294/GSM157294.CEL.gz","7129"
"GSM157295","Ovarian tumor AM398","GSM157295","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: endometrioid, Tumor stage: invasive grade 3, xenograft of an EOC cell line","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157295/GSM157295.CEL.gz","7129"
"GSM157296","Ovarian tumor AM429","GSM157296","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: clear cell, Tumor stage: invasive grade 3, xenograft of an EOC cell line","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157296/GSM157296.CEL.gz","7129"
"GSM157297","Ovarian tumor AM431","GSM157297","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: serous, Tumor stage: invasive grade 2","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157297/GSM157297.CEL.gz","7129"
"GSM157298","Ovarian tumor AM438","GSM157298","Public on Dec 31 2007","Jan 22 2007","Feb 25 2008","RNA","1","epithelian ovarian tumor","Homo sapiens","Tissue: epithelial ovarian tumor, Tumor type: mixed, Tumor stage: invasive grade 3","total RNA","Trizol extraction of total RNA was performed according to the manufacturer's instructions.","Biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 15 microg total RNA.","9606","15 ug of total RNA was reverse-transcribed with oligo-dT primer containing a T7 RNA polymerase-binding site. An in vitro transcription was performed on this cDNA. DNA from the samples was fragmented in 40 mM Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1) at 95°C to reduce secondary structures. 15 ug of cRNA were hybridized to an Affymetrix HuGeneFL microarray, washed and stained.","Scanned with a Hewlett Packard Gene Array Scanner","invasive","Raw values assigned by MAS 4","GPL80","Jaroslav,Petr,Novak","jaroslav.novak@mail.mcgill.ca, jaroslav.novak@gmail.com","450-465-1383","450-465-3033","Microarray Platform","McGill University and Genome Quebec Innovation Centre","740, Dr Penfield Avenue","Montreal","Quebec","H3A 1A4","Canada","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM157nnn/GSM157298/GSM157298.CEL.gz","7129"
